IRRITABLE BOWEL SYNDROME IN CHILDREN: BASELINE INFORMATION AND MODERN PARADIGM


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Irritable bowel syndrome (IBS) is a serious pediatric problem. The article describes the key clinical, diagnostic and therapeutic aspects of this disease, and provides the reference points for the correct diagnosis. The most recent information on the topic of discussion, in particular the canons of the Rome IV criteria, are presented. The article is intended to pediatricians, gastroenterologists, neurologists, and psychotherapists.

Full Text

Restricted Access

About the authors

V. F Privorotsky

St. Petersburg State Pediatric Medical University

Email: privorotsky@mail.ru
MD, Prof. at the Department of Gastroenterology FATPR

N. E Luppova

North-Western State Medical University n.a. I.I. Mechnikov

Department of Pediatrics and Cardiology

References

  1. Фролькис А.В. Функциональные заболевания желудочно-кишечного тракта. Л., 1991. 224 с.
  2. Rasquin A., Di Lorenzo C., Forbes D., et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130(5): 1527-37.
  3. Rome IV: Functional Gastrointestinal Disorders: Disorders of Gut-Brain Inetractions. Gastroenterology. 2016;4(150):1257-492.
  4. Caplan A., Walker L., Rasquin A. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. J. Pediatr. Gastroenterol. Nutr. 2005;41(3):305-16.
  5. Miele E., Simeone D., Marino A., et al. Functional gastrointestinal disorders in children: an Italian prospective survey. Pediatrics. 2004;114(1):73-8.
  6. Симаненков В.И. Психосоматические расстройства в практике терапевта: руководство для врачей. СПб., 2008. 335 с.
  7. Спиваковский Ю.М., Шульгина Е.Н., Эйберман А.С. и др. Синдром раздраженного кишечника у детей в свете Римских критериев-III и роль иммуномодулирующей терапии в коррекции основных проявлений болезни. РМЖ. 2010;5:255-59.
  8. Chiou Е., Nurko S. Functional abdominal pain and irritable bowel syndrome in children and adolescents Therapy. 2011;8(3):315-31.
  9. Levy R.L., Jones K.R., Whitehead W.E., et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121(4):799-804.
  10. Buonavolonta R., Coccorullo P., Turco R., et al. Familial aggregation in children affected by functional gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr. 2010;50(5):500-5.
  11. Saito Y.A., Mitra N., Mayer E.A. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010;138(4):1276-85.
  12. Ботвинев О.К., Еремеева А.В., Мохаммед Гамал Элдин Мансур Али. Клинические особенности синдрома раздраженного кишечника у детей. Вопросы детской диетологии. 2011;9(6):16-8.
  13. Barreau F., Ferrier L., Fioramonti J., Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: Contribution of neonatal stress models. Pediatr. Res. 2007;62(3):240-45.
  14. Anand K.J., Runeson B., Jacobson B. Gastric suction at birth associated with long-term risk for functional intestinal disorders in later life. J. Pediatr. 2004;144(4):449-54.
  15. Chitkara D.K., Rawat D.J., Talley N.J. The epidemiology of childhood recurrent abdominal pain in western countries: a systematic review. Am. J. Gastroenterol. 2005;100(8):1868-75.
  16. Campo J.V., Bridge J., Ehmann M., et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics. 2004;113(4):817-24.
  17. Schwille-Kiuntke J., Enck P., Zendler C., et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter Neurogastroenterol Motil. 2011;23(11):479-88.
  18. Saps M., Pensabene L., Di Martino L., et al. Post-infectious functional gastrointestinal disorders in children. J. Pediatr. 2008;152(6):812-16.
  19. Thabane M., Simunovic M., Akhtar-Danesh N., et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am. J. Gastroenterol. 2010;105(4):933-39.
  20. Marshall J.K., Thabane M., Borgaonkar M.R., James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin. Gastroenterol. Hepatol. 2007;5(4):457-60.
  21. Ringel Y., Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J. Clin. Gastroenterol. 2011;45:145-48.
  22. Guandalini S., Magazzu G., Chiaro A., et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebocontrolled, double-blind, crossover study. J. Pediatr. Gastroenterol. Nutr. 2010;51(1):24-30.
  23. Gawronska A., Dziechciarz P., Horvath A., Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment. Pharmacol. Ther. 2007; 25:177-84.
  24. Shulman R.J., Eakin M.N., Czyzewski D.I., et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J. Pediatr. 2008;153(5):646-50.
  25. Singh V.V., Toskes P.P. Small bowel bacterial overgrowth: Presentation, diagnosis, and treatment. Curr. Treat. Options Gastroenterol. 2004; 7(1):19-28.
  26. Barbara G., Stanghellini V, De Giorgio R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3): 693-702.
  27. Guilarte M., Santos J., De Torres I., et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56(2):203-9.
  28. Klooker T.K., Braak B., Koopman K.E., et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59(9):1213-21.
  29. Van Ginkel R., Voskuijl W.P, Benninga M.A., et al. Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome. Gastroenterology. 2001;120(1):31-38].
  30. Anderson J.L., Acra S., BruehlS., Walker L.S. Relation between clinical symptoms and experimental visceral hypersensitivity in pediatric patients with functional abdominal pain. J. Pediatr. Gastroenterol. Nutr. 2008;47(3):309-15.
  31. Dorn S.D., Palsson O.S., Thiwan S.I., et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007;56(9):1202-209.
  32. Keller J., Layer P Intestinal and anorectal motility and functional disorders. Best Pract. Res. Clin. Gastroenterol. 2009;23(3):407-23.
  33. Lee-Robichaud Н., Morgan J., Nelson R. L. Lactulose versus Polyethylene Glycol for Chronic Constipation [Intervention Review]).
  34. Bahar R.J., Collins B.S., Steinmetz B., Ament M.E. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J. Pediatr. 2008;152(5):685-89.
  35. Cann P., Read N., Holdsworth C., Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS) Dig. Dis. Sci. 1984; 29:239-47.
  36. Huertas-Ceballos A., Logan S., Bennett C., Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst. Rev. 2008;(1):CD003017.
  37. Huertas-Ceballos A., Logan S., Bennett C., Macarthur C. Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst. Rev. 2008;(1):CD003014.
  38. Vlieger A.M., Blink M., Tromp E., Benninga M.A. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics. 2008;122(2):446-51.
  39. Типикина М.Ю. Оценка роли воспалительных и микробиологических изменений при синдроме раздраженного кишечника у детей. Дисс. канд. мед. наук (автореферат). СПб., 2014, 23 с.
  40. Парфенов А.И., Ручкина И.Н., Атауллаханов Р.И. и др. Постинфекционный синдром раздраженного кишечника. Терапевтический архив. 2009;81(2):39-45.
  41. Ручкина И.Н., Парфенов А.И., Осипов Г.А. Постинфекционный синдром раздраженного кишечника - новое в этиологии и патогенезе функциональных. Consilium Medicum. 2006;Экстравыпуск:8-12. [Ruchkina I.N., Parfenov A.I., Osipov G.A. Consilium Medicum. 2006;suppl:8-12. (In Russ.)].
  42. Tomblom H., Holmvall P., Svenugsson B., Lindberg G. Gastrointestinal symptoms after infections diarrhea: a five year follow up in a swedish cohort of adults. Clin. Gastroenterol. Hepatol. 2007;5:461-64.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies